UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Changing predictor measurement procedures affected the performance of prediction models in clinical examples

Journal of clinical epidemiology, 2020-03, Vol.119, p.7-18

2020

Volltextzugriff (PDF)

Poor performance of clinical prediction models: the harm of commonly applied methods

Journal of clinical epidemiology, 2018-06, Vol.98, p.133-143

2018

Volltextzugriff (PDF)

Mutation Spectrum and Risk of Colorectal Cancer in African American Families with Lynch Syndrome

Gastroenterology (New York, N.Y. 1943), 2015-11, Vol.149 (6), p.1446-1453

2015

Volltextzugriff (PDF)

MyLynch: A Patient-Facing Clinical Decision Support Tool for Genetically-Guided Personalized Medicine in Lynch Syndrome

Cancers, 2023-01, Vol.15 (2), p.391

2023

Volltextzugriff (PDF)

Therapy-Associated Polyposis as a Late Sequela of Cancer Treatment

Clinical gastroenterology and hepatology, 2014-06, Vol.12 (6), p.1046-1050

2014

Volltextzugriff (PDF)

Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access

Genetics in medicine, 2022-06, Vol.24 (6), p.1196-1205

2022

Volltextzugriff (PDF)

Development and validation of the PREMMplus clinical prediction model for multigene hereditary cancer risk assessment

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.1579-1579

2020

Volltextzugriff (PDF)

Implementation of systematic genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts)

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.678-678

2020

Volltextzugriff (PDF)

Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study

Cancer medicine (Malden, MA), 2023-09, Vol.12 (18), p.19112-19125

2023

Volltextzugriff (PDF)

Clinical factors associated with urinary tract cancers (UTCs) among Lynch syndrome (LS) patients (Pts)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1517-1517

2018

Volltextzugriff (PDF)

Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The GENetic Education, Risk Assessment and TEsting (GENERATE) study

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.TPS779-TPS779

2020

Volltextzugriff (PDF)

Identification of Lynch syndrome (LS) in patients (pts) without prior LS-associated cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.1521-1521

2016

Volltextzugriff (PDF)

Implementing universal genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1512-1512

2018

Volltextzugriff (PDF)

Prevalence of germline cancer susceptibility gene mutations in a consecutive series of 799 colorectal cancer (CRC) patients (pts)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.1501-1501

2016

Volltextzugriff (PDF)

Abstract 4272: Mutations in RABL3 alter RAS prenylation and are associated with hereditary pancreatic cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4272-4272

2017

Volltextzugriff (PDF)

Therapy-associated polyposis – a novel form of acquired gastrointestinal polyposis

Clinical gastroenterology and hepatology, 2013-12, Vol.12 (6), p.1046-1050

2013

Volltextzugriff (PDF)

Cancer risks and mutation spectrum of mismatch repair genes in African American families with Lynch syndrome

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.1530-1530

2013

Volltextzugriff (PDF)

Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome

Journal of clinical oncology, 2017-07, Vol.35 (19), p.2165-2172

2017

Volltextzugriff (PDF)

Mutational signature profiling classifies subtypes of clinically different mismatch-repair-deficient tumours with a differential immunogenic response potential

British journal of cancer, 2022-06, Vol.126 (11), p.1595-1603

2022

Volltextzugriff (PDF)

Clinical Factors Associated With Gastric Cancer in Individuals With Lynch Syndrome

Clinical gastroenterology and hepatology, 2020-04, Vol.18 (4), p.830-837.e1

2020

Volltextzugriff (PDF)

Tu1018 A MIXED METHODS APPROACH TO ASSESSING BARRIERS AND FACILITATORS TO CANCER GENETICS CARE IN BLACK AND LATINO/A/X INDIVIDUALS AFFECTED BY PANCREATIC CANCER: THE RACIAL/ETHNIC GENETIC EDUATION, RISK ASSESSMENT, AND TESTING (REGENERATE) STUDY

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1221-S-1222

2024

Volltextzugriff (PDF)

Implementing systematized patient-facing Lynch syndrome (LS) risk assessment in oncology using the electronic health record (EHR) system

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.10503-10503

2022

Volltextzugriff (PDF)

Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5™) for lynch syndrome risk assessment in a diverse population

Familial cancer, 2022-04, Vol.21 (2), p.167-180

2022

Volltextzugriff (PDF)

Comparison of Colorectal and Endometrial Microsatellite Instability Tumor Analysis and Premm5 Risk Assessment for Predicting Pathogenic Germline Variants on Multigene Panel Testing

Journal of clinical oncology, 2020-12, Vol.38 (34), p.4086-4094

2020

Volltextzugriff (PDF)

Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals

Familial cancer, 2021-04, Vol.20 (2), p.111-116

2021

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Aktive Filter

ThemaGenetic Predisposition To Disease

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(53)

Sprache

Englisch
(53)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Humans
(16)
Female
(13)
Oncology
(13)
Male
(11)
Middle Aged
(10)
Colorectal Cancer
(8)
Colorectal Neoplasms, Hereditary Nonpolyposis - Genetics
(8)
Adult
(7)
Germ-Line Mutation
(7)
Aged
(6)
Epidemiology
(6)
Genetic Disorders
(6)
Genetic Testing
(6)
Lynch Syndrome
(6)
Age Factors
(5)
Dna Mismatch Repair - Genetics
(5)
Family Medical History
(5)
Genetics & Heredity
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Changing predictor measurement procedures affected the performance of prediction models in clinical examples

Poor performance of clinical prediction models: the harm of commonly applied methods

Mutation Spectrum and Risk of Colorectal Cancer in African American Families with Lynch Syndrome

MyLynch: A Patient-Facing Clinical Decision Support Tool for Genetically-Guided Personalized Medicine in Lynch Syndrome

Therapy-Associated Polyposis as a Late Sequela of Cancer Treatment

Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access

Development and validation of the PREMMplus clinical prediction model for multigene hereditary cancer risk assessment

Implementation of systematic genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts)

Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study

Clinical factors associated with urinary tract cancers (UTCs) among Lynch syndrome (LS) patients (Pts)

Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The GENetic Education, Risk Assessment and TEsting (GENERATE) study

Identification of Lynch syndrome (LS) in patients (pts) without prior LS-associated cancer

Implementing universal genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts)

Prevalence of germline cancer susceptibility gene mutations in a consecutive series of 799 colorectal cancer (CRC) patients (pts)

Abstract 4272: Mutations in RABL3 alter RAS prenylation and are associated with hereditary pancreatic cancer

Therapy-associated polyposis – a novel form of acquired gastrointestinal polyposis

Cancer risks and mutation spectrum of mismatch repair genes in African American families with Lynch syndrome

Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome

Mutational signature profiling classifies subtypes of clinically different mismatch-repair-deficient tumours with a differential immunogenic response potential

Clinical Factors Associated With Gastric Cancer in Individuals With Lynch Syndrome

Tu1018 A MIXED METHODS APPROACH TO ASSESSING BARRIERS AND FACILITATORS TO CANCER GENETICS CARE IN BLACK AND LATINO/A/X INDIVIDUALS AFFECTED BY PANCREATIC CANCER: THE RACIAL/ETHNIC GENETIC EDUATION, RISK ASSESSMENT, AND TESTING (REGENERATE) STUDY

Implementing systematized patient-facing Lynch syndrome (LS) risk assessment in oncology using the electronic health record (EHR) system

Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5™) for lynch syndrome risk assessment in a diverse population

Comparison of Colorectal and Endometrial Microsatellite Instability Tumor Analysis and Premm5 Risk Assessment for Predicting Pathogenic Germline Variants on Multigene Panel Testing

Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals

Aktive Filter

Suchergebnisse filtern